Testing effectiveness (Phase 2)Study completedNCT02430480
What this trial is testing
Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer
Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 39